Providing Industry-Dedicated Content & Uniting CNS Drug Developers
January 2024 | Boston, MA
Delivering & Translating Degraders of Extracellular & Intracellular CNS Proteins
January 2024 | San Francisco, CA
Uniting Pharma & Biotech to Accelerate Development of Delivering Long-Lasting Ophthalmic Therapies
March 2024 | Boston, MA
Translating Neuroimmunological Targets & Neuroinflammatory Biomarkers to Revolutionize Neurological Drug Development
April 2024 | Boston, MA
Uniting CNS Biopharma to Revolutionize the Next Wave of Neurodegenerative Therapeutics
May 2024 | Boston, MA
Revolutionizing ALS Biomarkers to Accelerate the Translation of Efficacious Drugs into Clinic
June 2024 | Boston, MA
Innovating Imaging Measures of Disease Progression & Improvement to Determine Drug Efficacy Sooner
July 2024 | Boston, MA
Enhance Delivery & Distribution of Safe & Potent Oligonucleotides to the CNS
August 2024 | Boston, MA
More Objectively, Frequently & Sensitively Diagnose & Monitor Patients to Robustly Prove Drug Efficacy in Neurological Trials
September 2024 | Boston, MA
Progress Clinical Pipelines, Optimize Translation, Employ Ground-breaking Neuroscience and Direct Commercial Strategies to Create Successful Psychiatric Therapeutics
October 2024 | Boston, MA
Advance Biomarker Assessment to More Sensitively Translate CNS Drugs
November 2024 | Boston, MA
Enhance Delivery, Pharmacokinetics & Pharmacodynamics Beyond the Barriers of the Brain, & Advance the Next Generation of Administration Technologies
Get a comprehensive overview of the upcoming events within the World CNS Series portfolio. If you have any questions, get in touch at info@hansonwade.com